Baptist Health Foundation Presents Endowed Chair Ceremony for Aviva Abosch, M.D., Ph.D. - Summary - MDSpire

Baptist Health Foundation Presents Endowed Chair Ceremony for Aviva Abosch, M.D., Ph.D.

Aviva Abosch, M.D., Ph.D., a neurosurgeon at Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain and Spine Care, was installed as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.

  • By

  • May 21, 2026

  • 5 min

Share

Objective:

To announce the installation of Aviva Abosch, M.D., Ph.D., as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.

Key Findings:
  • The Esernia Endowed Chair was established in 2025 with a $2 million gift from Anthony and Joyce Esernia.
  • Dr. Abosch is recognized for her work in functional neurosurgery and deep brain stimulation.
  • Movement disorders and epilepsy significantly impact quality of life, with Parkinson's disease affecting at least 1% of the population (source needed).
Interpretation:

Limitations:
  • The article does not provide specific data on the expected outcomes of the endowed chair's establishment.
  • No detailed metrics on the impact of Dr. Abosch's previous work or the current state of research at the Miami Neuroscience Institute are included.
Conclusion:

Original Source(s)

Baptist Health Foundation Presents Endowed Chair Ceremony for Aviva Abosch, M.D., Ph.D.

  • by

  • May 21, 2026

Related Content

MRI May Define Two Distinct Migraine Phenotypes

Patients with greater migraine burden showed widespread connectivity changes and lower cortical volume.

2026 Brain and Spine Symposium Highlights Advances Across the Neurosciences

Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.

  • by

  • May 21, 2026

  • 1 min
CGRP Therapies Reduced Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies